Taeyang Corp

Taeyang Corp maintains a strong liquidity position, with a current ratio of 3.15, indicating that the company has more than three times the current assets to cover its current liabilities. The company's cash and equivalents amount to KRW 69,983,139,010, which is a significant portion of its total assets, further supporting its liquidity profile. The liquidity_fpt metric confirms that the company is well-positioned to meet short-term obligations without relying on external financing.

In terms of profitability, Taeyang Corp's return on equity (ROE) is 0.81%, and its return on assets (ROA) is 0.66%. These figures are below the industry median for commodity chemicals, suggesting that the company is not generating returns as efficiently as its peers. The operating margin, calculated as operating income divided by revenue, is 1.67%, which is also below the industry median, indicating that the company is facing margin compression or higher cost pressures.

The company's revenue is concentrated in a single business segment, as disclosed in its latest financial report, with no material geographic diversification beyond South Korea. This lack of diversification increases the company's exposure to regional economic fluctuations and regulatory changes, which could impact its revenue stability.

Looking ahead, Taeyang Corp's revenue is projected to grow by 2.5% in the current fiscal year and by 1.8% in the next fiscal year, based on the latest outlook data. This growth is modest compared to the industry average and is primarily driven by stable demand in the energy and basic materials sectors. The company's capital expenditure is negative, indicating that it is not investing in new projects or capacity expansion, which may limit its long-term growth potential.

The risk assessment for Taeyang Corp indicates a low probability of dilution and no immediate liquidity concerns. The company's debt-to-equity ratio is 0.0, meaning it is not leveraged and does not rely on debt financing. However, the absence of debt also suggests that the company is not utilizing financial leverage to enhance returns, which could be a missed opportunity in a capital-intensive industry. The risk assessment also notes that no immediate filing-based liquidity or dilution flags were detected, indicating a stable capital structure.

Recent filings and transcripts do not indicate any material events or strategic shifts for Taeyang Corp. The company has not disclosed any major new projects, partnerships, or regulatory challenges that would significantly impact its operations or financial performance. The absence of recent events suggests a stable but uneventful operating environment, with no clear catalysts for near-term growth or transformation.

Net income surged 43.5% year-over-year to 11.85 billion KRW, demonstrating strong profitability growth despite revenue declines.

Free cash flow increased 54.7% to 15.12 billion KRW, indicating robust cash generation capabilities for the company.

The company maintains a zero debt-to-equity ratio, ranking in the top quartile compared to the commodity chemicals cohort median.

Cash conversion of 2.09 significantly exceeds the cohort median of 1.1, highlighting superior efficiency in turning earnings into cash.

Net income compound annual growth rate reached 25.3% over four years, showing consistent long-term earnings expansion.

Return on equity of 0.81% is significantly lower than the cohort median of 3.61%, reflecting weak capital utilization.

Net margin of 3.77% trails the cohort median of 4.17%, suggesting the company captures less profit per unit of sales.

Revenue compound annual growth rate was negative 1.7% over four years, indicating a long-term contraction in sales volume.